Vanguard Personalized Indexing Management
RMD icon

Vanguard Personalized Indexing Management’s ResMed RMD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.24M Sell
26,905
-1,058
-4% -$219K 0.04% 352
2026
Q1 		$6.28M Sell
27,963
-1,327
-5% -$331K 0.06% 268
2025
Q4 		$7.06M Sell
29,290
-1,241
-4% -$317K 0.07% 235
2025
Q3 		$8.36M Sell
30,531
-199
-0.6% -$54.4K 0.09% 196
2025
Q2 		$7.93M Buy
30,730
+4,424
+17% +$1.06M 0.09% 191
2025
Q1 		$5.89M Buy
26,306
+2,301
+10% +$537K 0.09% 202
2024
Q4 		$5.49M Buy
24,005
+648
+3% +$156K 0.08% 203
2024
Q3 		$5.7M Buy
23,357
+2,769
+13% +$619K 0.09% 188
2024
Q2 		$3.89M Buy
20,588
+2,175
+12% +$441K 0.07% 231
2024
Q1 		$3.65M Buy
18,413
+715
+4% +$131K 0.08% 227
2023
Q4 		$3.04M Buy
17,698
+10,074
+132% +$1.55M 0.08% 236
2023
Q3 		$1.13M Buy
7,624
+252
+3% +$45.6K 0.03% 505
2023
Q2 		$1.61M Sell
7,372
-98
-1% -$21.8K 0.05% 370
2023
Q1 		$1.64M Buy
7,470
+233
+3% +$50.5K 0.06% 350
2022
Q4 		$1.51M Sell
7,237
-3,549
-33% -$780K 0.06% 354
2022
Q3 		$2.35M Buy
10,786
+2,392
+28% +$544K 0.11% 190
2022
Q2 		$1.76M Buy
8,394
+2,456
+41% +$523K 0.08% 243
2022
Q1 		$1.44M Buy
5,938
+2,188
+58% +$529K 0.07% 280
2021
Q4 		$977K Buy
3,750
+657
+21% +$170K 0.06% 402
2021
Q3 		$815K Buy
3,093
+536
+21% +$147K 0.07% 291
2021
Q2 		$630K Buy
2,557
+1,056
+70% +$222K 0.07% 383
2021
Q1 		$291K Sell
1,501
-65
-4% -$13K 0.04% 516
2020
Q4 		$333K Buy
1,566
+230
+17% +$45.9K 0.07% 330
2020
Q3 		$229K Buy
+1,336
New +$247K 0.06% 367

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Personalized Indexing Management's RMD Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its ResMed (RMD) stake by 3.8% in Q2 2026, selling an estimated $219K and leaving 26,905 shares worth $5.24M. The position accounts for 0.04% of the portfolio, ranked #352.

Vanguard Personalized Indexing Management first reported a position in RMD in Q3 2020 and has held it in 24 quarters since. The position peaked at $8.36M in Q3 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Vanguard Personalized Indexing Management held 26,905 shares of ResMed worth $5.24M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 1,058 ResMed shares in Q2 2026, an estimated $219K.
  • ResMed made up 0.04% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #352 holding.
  • Vanguard Personalized Indexing Management first reported a position in ResMed in Q3 2020 and has held it in 24 quarters since.
  • Vanguard Personalized Indexing Management's ResMed position peaked at $8.36M in Q3 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.